ALLSCRIPTS INC /IL
8-K, 2000-07-27
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: AUSTRALIAN CANADIAN OIL ROYALTIES LTD, DEF 14A, 2000-07-27
Next: ALLSCRIPTS INC /IL, 8-K, EX-99, 2000-07-27



                       SECURITIES AND EXCHANGE COMMISSION
                             Washington , D.C. 20549

                                  -------------

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934



         Date of report (Date of earliest event reported): July 13, 2000
                                                           -------------


                                ALLSCRIPTS, INC.
             (Exact Name of Registrant as Specified in its Charter)

<TABLE>
<S>                                         <C>                                 <C>
            DELAWARE                                000-26537                               36-3444974
(State or other jurisdiction of              (Commission File Number)           (IRS Employer Identification No.)
 incorporation or organization)

</TABLE>


                               2401 COMMERCE DRIVE
                          LIBERTYVILLE, ILLINOIS 60048
              (Address of principal executive offices and zip code)


       Registrant's telephone number, including area code: (847) 680-3515


                                       N/A
          (Former name or former address, if changed since last report)


<PAGE>
                    INFORMATION TO BE INCLUDED IN THE REPORT

Item 5. OTHER EVENTS.

                     On July 13, 2000, Allscripts, Inc. ("Allscripts") and IDX
Systems Corporation, a Vermont corporation ("IDX"), jointly issued a press
release (the "Press Release") announcing the signing of an Agreement and Plan of
Merger, dated as of July 13, 12000 (the "Merger Agreement"), by and among
Allscripts, IDX, Allscripts Holding, Inc, a Delaware corporation and
wholly-owned subsidiary of Allscripts ("New Allscripts"), Bursar Acquisition,
Inc., a Delaware corporation and wholly-owned subsidiary of New Allscripts
("Bursar"), Bursar Acquisition No. 2, Inc., a Delaware corporation and
wholly-owned subsidiary of New Allscripts ("Bursar No. 2") and Channelhealth
Incorporated, a Delaware corporation and approximately 90%-owned subsidiary of
IDX ("Channelhealth"). Pursuant to the Merger Agreement, Bursar will be merged
with and into Allscripts and Bursar No. 2 will be merged with and into
Channelhealth with each of Allscripts and Channelhealth continuing as a
surviving corporation (the "Mergers"). Each of Allscripts and Channelhealth will
become a wholly owned subsidiary of New Allscripts and former stockholders of
Allscripts and Channelhealth will become stockholders of New Allscripts.

                     Pursuant to the Merger Agreement, (a) each outstanding
share of common stock, par value $.01 per share, of Allscripts ("Allscripts
Common Stock") will be converted into one share of common stock, par value $.01
per share, of New Allscripts ("New Allscripts Common Stock") and (b) each
outstanding share of common stock, par value $.001 per share, of Channelhealth
("Channelhealth Common Stock") and each outstanding share of Series A Preferred
Stock, par value $.001 per share of Channelhealth ("Channelhealth Preferred
Stock", and together with the Channelhealth Common Stock, the "Channelhealth
Stock") will be converted into .33730 shares of New Allscripts Common Stock.
Holders of Allscripts Common stock or Channelhealth Stock, as applicable, who
would receive fractional shares of New Allscripts Common Stock will instead
receive an amount in cash equal to the product obtained by multiplying (i) the
fractional share interest to which such holder would otherwise be entitled
(after taking into account all shares of Allscripts Common Stock or
Channelhealth Stock held on the date of closing of the transactions contemplated
by the Merger Agreement (the "Closing Date") by such holder) by (ii) the closing
price for a share of New Allscripts Common Stock on the Nasdaq Stock Market,
Inc. on the first trading day following the Closing Date.

                     Pursuant to the Merger Agreement, New Allscripts will issue
to Channelhealth's stockholders an aggregate of approximately 8,593,003 shares
of New Allscripts Common Stock, and to Allscripts stockholders an aggregate of
approximately 31,771,002 shares of New Allscripts Common Stock. The transactions
are expected to qualify as tax-free organizations for U.S. federal income tax
purposes and the acquisition of Channelhealth will be accounted for as a
purchase.

                     On the Closing Date, IDX and New Allscripts will enter into
a Stock Rights and Restrictions Agreement pursuant to which each party will
agree to certain restrictions on its activities as a stockholder in the other
(including with respect to the voting of shares held in certain circumstances),
IDX will agree to restrictions on its ability to sell, transfer or otherwise
dispose of its shares in New Allscripts and its ability to purchase additional
shares of New Allscripts and New Allscripts will agree to appoint an IDX
representative to its Board of Directors so long as certain conditions are met.


                                       2
<PAGE>
                     On the Closing Date, New Allscripts and IDX will enter into
a ten-year strategic alliance involving the development and marketing of their
complementary products and New Allscripts will become the exclusive provider of
point of care clinical applications sold by IDX to physician practices.

                     A copy of the Press Release is attached hereto as Exhibit
99.1 and is incorporated herein by reference. A copy of the Merger Agreement is
attached hereto as Exhibit 99.2 and is incorporated herein by reference.


Item 7.  FINANCIAL STATEMENTS AND EXHIBITS.

           The following exhibits are filed herewith:

           99.1  Joint Press Release of Allscripts, Inc. and IDX Systems
                 Corporation, dated July 13, 2000.

           99.2  Agreement and Plan of Merger.


         Exhibit No.                          Description
         -----------                          -----------

           99.1            --Joint Press Release of Allscripts, Inc. and IDX
                           Systems Corporation, dated July 13, 2000.

           99.2            --Agreement and Plan of Merger, dated as of July 13,
                           2000, by and among Allscripts Holding, Inc.,
                           Allscripts, Inc., Bursar Acquisition, Inc., Bursar
                           Acquisition No. 2, Inc., IDX Systems Corporation and
                           Channelhealth Incorporated.





                                       3
<PAGE>
                                   SIGNATURES

                     Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.


                                            ALLSCRIPTS, INC.

                                            By: /s/ David B. Mullen
                                                ------------------------------
                                                David B. Mullen
                                                President




                                            Date:  July 27, 2000













                                       4
<PAGE>
                                  EXHIBIT INDEX



         Exhibit No.                           Description
         -----------                           -----------

           99.1            --Joint Press Release of Allscripts, Inc. and IDX
                           Systems Corporation

           99.2            --Agreement and Plan of Merger, dated as of July 13,
                           2000, by and among Allscripts Holding, Inc.,
                           Allscripts, Inc., Bursar Acquisition, Inc., Bursar
                           Acquisition No. 2, Inc., IDX Systems Corporation and
                           Channelhealth Incorporated.













                                       5


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission